Articles with public access mandates - Andreas von DeimlingLearn more
Not available anywhere: 37
Brain tumour cells interconnect to a functional and resistant network
M Osswald, E Jung, F Sahm, G Solecki, V Venkataramani, J Blaes, S Weil, ...
Nature 528 (7580), 93-98, 2015
Mandates: German Research Foundation
Actively personalized vaccination trial for newly diagnosed glioblastoma
N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ...
Nature 565 (7738), 240-245, 2019
Mandates: Cancer Research UK, UK Medical Research Council
A vaccine targeting mutant IDH1 induces antitumour immunity
T Schumacher, L Bunse, S Pusch, F Sahm, B Wiestler, J Quandt, O Menn, ...
Nature 512 (7514), 324-327, 2014
Mandates: US National Institutes of Health, German Research Foundation
Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets
F Sahm, D Schrimpf, DTW Jones, J Meyer, A Kratz, D Reuss, D Capper, ...
Acta neuropathologica 131, 903-910, 2016
Mandates: Helmholtz Association
Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity
A Korshunov, D Capper, D Reuss, D Schrimpf, M Ryzhova, V Hovestadt, ...
Acta neuropathologica 131, 137-146, 2016
Mandates: Cancer Research UK, Wellcome Trust, Brain Tumour Charity, UK
Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo
S Pusch, S Krausert, V Fischer, J Balss, M Ott, D Schrimpf, D Capper, ...
Acta neuropathologica 133, 629-644, 2017
Mandates: Helmholtz Association, Federal Ministry of Education and Research, Germany
Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma
K Ochs, F Sahm, CA Opitz, TV Lanz, I Oezen, PO Couraud, ...
Journal of neuroimmunology 265 (1-2), 106-116, 2013
Mandates: German Research Foundation
Detection of the BRAF V600E mutation in serous ovarian tumors: a comparative analysis of immunohistochemistry with a mutation-specific monoclonal antibody and allele-specific PCR
H Bösmüller, A Fischer, DL Pham, T Fehm, D Capper, A Von Deimling, ...
Human pathology 44 (3), 329-335, 2013
Mandates: US National Institutes of Health
Biological and clinical heterogeneity of MYCN-amplified medulloblastoma
A Korshunov, M Remke, M Kool, T Hielscher, PA Northcott, D Williamson, ...
Acta neuropathologica 123, 515-527, 2012
Mandates: Cancer Research UK
Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain
C Geisenberger, A Mock, R Warta, C Rapp, C Schwager, A Korshunov, ...
Acta neuropathologica 130, 419-434, 2015
Mandates: US National Institutes of Health
Identification of novel oligodendroglioma‐associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray‐based expression profiling
B Tews, J Felsberg, C Hartmann, A Kunitz, M Hahn, G Toedt, K Neben, ...
International journal of cancer 119 (4), 792-800, 2006
Mandates: German Research Foundation
Nonmetastatic medulloblastoma of early childhood: results from the prospective clinical trial HIT-2000 and an extended validation cohort
M Mynarek, K von Hoff, T Pietsch, H Ottensmeier, M Warmuth-Metz, ...
Journal of clinical oncology 38 (18), 2028-2040, 2020
Mandates: Helmholtz Association
Interlaboratory comparison of IDH mutation detection
MJ Van Den Bent, C Hartmann, M Preusser, T Ströbel, HJ Dubbink, ...
Journal of neuro-oncology 112, 173-178, 2013
Mandates: US National Institutes of Health
Suppression of TDO‐mediated tryptophan catabolism in glioblastoma cells by a steroid‐responsive FKBP52‐dependent pathway
M Ott, UM Litzenburger, KJ Rauschenbach, L Bunse, K Ochs, F Sahm, ...
Glia 63 (1), 78-90, 2015
Mandates: German Research Foundation
Infratentorial IDH-mutant astrocytoma is a distinct subtype
R Banan, D Stichel, A Bleck, B Hong, U Lehmann, A Suwala, A Reinhardt, ...
Acta neuropathologica 140, 569-581, 2020
Mandates: German Research Foundation
Tryptophan‐2, 3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4
K Ochs, M Ott, KJ Rauschenbach, K Deumelandt, F Sahm, CA Opitz, ...
Journal of neurochemistry 136 (6), 1142-1154, 2016
Mandates: German Research Foundation, Helmholtz Association
Targeting resistance against the MDM2 inhibitor RG7388 in glioblastoma cells by the MEK inhibitor trametinib
A Berberich, T Kessler, CM Thomé, S Pusch, T Hielscher, F Sahm, ...
Clinical Cancer Research 25 (1), 253-265, 2019
Mandates: Helmholtz Association
BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts
L Schweizer, D Capper, A Hölsken, R Fahlbusch, J Flitsch, M Buchfelder, ...
Neuropathology and Applied Neurobiology 41 (6), 733-742, 2015
Mandates: German Research Foundation
BRAF V 600 E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma
C Koelsche, F Sahm, W Paulus, M Mittelbronn, F Giangaspero, ...
Neuropathology and Applied Neurobiology 40 (3), 337-344, 2014
Mandates: German Research Foundation
Desmoplastic myxoid tumor, SMARCB1-mutant: clinical, histopathological and molecular characterization of a pineal region tumor encountered in adolescents and adults
C Thomas, A Wefers, S Bens, K Nemes, A Agaimy, F Oyen, ...
Acta neuropathologica 139, 277-286, 2020
Mandates: German Research Foundation
Publication and funding information is determined automatically by a computer program